Cad risk
Searched over 200M research papers for "cad risk"
Summary
10 papers analyzed
These studies suggest that genetic risk scores, including polygenic and genomic risk scores, effectively stratify individuals' coronary artery disease risk and improve prediction when combined with clinical risk factors, while identifying new genetic loci associated with the disease.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Coronary Artery Disease (CAD) Risk: Genetic and Conventional Factors
Genetic Risk Prediction for CAD
Genomic Risk Scores (GRS) and Polygenic Risk Scores (PRS)
Recent studies have highlighted the significant role of genetic factors in predicting the risk of coronary artery disease (CAD). A comprehensive study developed a genomic risk score (metaGRS) incorporating 1.7 million genetic variants, which demonstrated a strong association with CAD risk. Individuals in the top 20% of the metaGRS distribution had a hazard ratio (HR) of 4.17 for CAD compared to those in the bottom 20%. This score outperformed traditional risk factors such as smoking, diabetes, and hypertension in predicting CAD.
Similarly, a meta-analysis of nearly one million participants confirmed that polygenic risk scores (PRS) are significantly associated with both incident and prevalent CAD. The PRSmetaGRS showed an odds ratio (OR) of 1.67 per standard deviation increase, indicating a robust predictive capability. These findings suggest that genetic risk scores can be valuable tools for early identification and prevention strategies in high-risk individuals.
New Genetic Loci and Their Implications
Large-scale genetic studies have identified several new susceptibility loci for CAD. For instance, a meta-analysis involving over 22,000 CAD cases and 64,000 controls identified 13 new loci associated with CAD, with risk allele frequencies ranging from 0.13 to 0.91. These loci were associated with a 6% to 17% increase in CAD risk per allele, highlighting the complex genetic architecture of the disease.
Moreover, a genome-wide association study in the Japanese population identified eight new susceptibility loci and several Japanese-specific rare variants that contribute to CAD severity and increased cardiovascular mortality. A trans-ancestry meta-analysis further discovered 35 additional loci, underscoring the importance of diverse genetic studies in understanding CAD risk.
Conventional Risk Factors and Their Interaction with Genetic Risk
Traditional Risk Factors
Conventional risk factors such as diabetes mellitus, hypertension, smoking, hyperlipidemia, obesity, and psychosocial stress remain significant contributors to CAD. These factors often interact with genetic predispositions, exacerbating the overall risk. For example, individuals with high genetic risk scores who also have multiple conventional risk factors reach a 10% cumulative risk of CAD by the age of 48.
Risk Prediction Models
Various history-based risk scores have been developed to predict obstructive CAD in patients with stable chest pain. Among these, the CAD Consortium clinical score (CAD2) demonstrated the highest discrimination and classification performance, followed by the CONFIRM risk score (CRS) and the updated Diamond-Forrester score (UDF). These models help in stratifying patients based on their risk levels and guiding clinical decision-making.
Population-Specific Insights
South Asians and CAD Risk
South Asians exhibit a higher risk for CAD due to a combination of conventional risk factors and unique conditioning factors such as socioeconomic status, education, and early life influences. This population-specific risk necessitates a life course approach to effectively manage and mitigate CAD risk.
Genetic Variants and Lipid Levels
Genetic studies have also identified novel loci associated with lipid levels, which are crucial in CAD pathogenesis. For instance, variants in the SLC39A8 gene for HDL-C and the MYLIP/GMPR and PPP1R3B genes for LDL-C have been linked to CAD risk. These findings provide new insights into the biological mechanisms underlying lipid metabolism and CAD.
Conclusion
The integration of genetic risk scores with conventional risk factors offers a comprehensive approach to predicting and managing CAD risk. Advances in genomic research have identified numerous genetic loci associated with CAD, enhancing our understanding of the disease's complex etiology. Population-specific studies further underscore the need for tailored prevention strategies. As research progresses, the use of genetic information in clinical practice holds promise for early intervention and improved outcomes in CAD management.
Sources and full results
Most relevant research papers on this topic
